Retatrutide Beats Ozempic in Head-to-Head Diabetes Trial, Producing Roughly Double the Weight Loss
If you or someone you know manages type 2 diabetes and has been watching the weight-loss drug space, a new clinical trial result has changed the comparison. Eli Lilly’s retatrutide outperformed semaglutide